The PMTA process costs $1-10 million per product. State licensing, age verification, and reporting requirements add thousands more. The compliance costs of nicotine regulation create a market accessible only to the largest corporations.
Nicotine use produces pleasure—and guilt about the pleasure. The combination of pleasure and guilt is psychologically destabilizing, making nicotine use simultaneously more appealing (the forbidden fruit) and more distressing (the shame).
Social support is one of the strongest predictors of cessation success. It's also one of the hardest things to provide through the healthcare system. The gap between the importance of social support and its availability is a central challenge of cessation.
Sweden has the lowest smoking rate in Europe—achieved not through abstinence but through snus, a reduced-risk oral product. The Swedish model is the strongest evidence for harm reduction. Can it be replicated elsewhere?
Disposable vapes are designed to be thrown away. A handful of startups and environmental initiatives are trying to change that—developing recycling systems for the lithium batteries, circuit boards, and plastics. The quest is difficult. It's also essential.
The major nicotine companies all claim to be transitioning to a 'smoke-free future.' The claims are partly true—and partly strategic. Understanding what's real and what's rhetoric is essential to evaluating the industry's transformation.
industry changestransformationrhetoricstrategyevaluation
Smoking increases the risk of sleep apnea—and sleep apnea makes smoking harder to quit. The relationship is bidirectional, clinically significant, and almost never discussed in cessation support. Treating sleep disorders should be part of cessation care.
Smoking prevalence among homeless populations exceeds 70%—the highest of any demographic group. The cigarette is a coping mechanism for the most extreme stress, a currency in the street economy, and one of the last remaining pleasures for people who have lost almost everything.
The strongest predictor of youth nicotine use is parental smoking. The most effective prevention strategy is parental cessation. And yet youth prevention programs almost never address parental behavior. The omission is political, not evidence-based.
Across the American South, tobacco festivals persist—celebrations of a crop that is declining, a way of life that is disappearing. The festivals are awkward, contested, and revealing of the complex relationship between communities and the crop that sustained them.
Nicotine policies spread through a process of diffusion—countries adopt policies that have been successful elsewhere. The diffusion can be evidence-based (the UK model spreading to New Zealand) or ideology-based (the WHO's abstinence model spreading to LMICs).
Nicotine users are stigmatized, excluded, and isolated. Online communities—forums, social media groups, advocacy networks—are creating solidarity among a population that has been systematically divided. The solidarity movement is the foundation of consumer power.
Diet affects nicotine craving, withdrawal severity, and cessation success. Specific nutritional strategies—increasing fiber, managing blood sugar, avoiding alcohol—can support the quit attempt. Nutrition is an underutilized tool in smoking cessation.
Nicotine consumers have almost no formal rights: no right to accurate information, no right to product safety, no right to participate in the policy process. A consumer rights framework would transform nicotine governance.
public healthconsumer rightsframeworkgovernanceparticipation
The flavor in your vape is a complex mixture of synthetic and natural aroma chemicals—the same molecules used in food, but inhaled rather than ingested. The flavor chemistry of vaping is a vast, largely uncharted territory of inhalation toxicology.
Every generation born since the 1950s has smoked less than the one before. The generational decline is the most powerful force in tobacco control. Understanding it is essential to predicting the future of nicotine.
Genetic variation in nicotinic receptor genes explains up to 50% of the variance in nicotine dependence. The genetics of addiction are real, clinically relevant, and almost never discussed with smokers. Personalized cessation based on genetics is coming.
Taxi and rideshare drivers smoke at elevated rates. The job—sedentary, stressful, solitary, with long hours and irregular breaks—is a perfect storm for nicotine dependence. The gig economy has a smoking problem, and it's almost entirely unaddressed.
College students use nicotine at significant rates. Almost no university provides adequate cessation support. The gap between the prevalence of nicotine use on campus and the availability of help is a public health failure hiding in plain sight.
Individual tobacco farmers have no bargaining power against the global industry. Cooperatives—farmer-owned organizations that negotiate prices, provide services, and support diversification—could change that. The cooperative model is proven in other crops. It's underused in tobacco.
Nicotine products are subject to a patchwork of safety standards—or none at all. Meaningful safety regulation would include contaminant limits, ingredient disclosure, manufacturing standards, and post-market surveillance. It exists for pharmaceuticals. It doesn't exist for consumer nicotine.
The stories smokers tell about their quit attempts—to themselves and to others—are not just descriptions. They're tools. The recovery narrative can support the quit or sabotage it. Learning to tell a helpful story is part of learning to quit.
Motivation to quit is not constant. It fluctuates—peaking at certain moments (health scares, New Year's resolutions, the birth of a child) and crashing at others. The motivation window is the key concept for timing a quit attempt for maximum success.
Nicotine research is funded by governments, philanthropies, and industry. Each funder has interests. The funding shapes the research—not through crude manipulation, but through the subtle mechanisms of agenda-setting, framing, and selective publication.
public healthresearchfundingbiasscience
Products
Explore VAPEPIE devices
Select a product to view details, highlights, and technical specifications.